Literature DB >> 18055158

Thermal ablation of hepatic malignancy: useful but still not optimal.

M B Nicholl1, A J Bilchik.   

Abstract

The mortality associated with primary and metastatic hepatic malignancies remains high because few patients are candidates for hepatic resection or transplantation. Resection is the most effective treatment for liver tumors but may be contraindicated by factors such as the tumor's location; hepatic transplantation can cure primary hepatocellular carcinoma and underlying cirrhosis, but a donor may not be immediately available. When resection or transplantation is not possible, thermal ablation is a reasonable therapeutic option. Effective destruction of tumors can be achieved with low recurrence rates and minimal complications or risk of death. In patients with primary hepatic malignancy, ablation treatment does not preclude subsequent transplantation. Although radiofrequency ablation is currently the most widely used thermal ablative technique for hepatic malignancy, microwave ablation is gaining popularity and eventually may prove to be more effective.

Entities:  

Mesh:

Year:  2007        PMID: 18055158     DOI: 10.1016/j.ejso.2007.07.203

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases.

Authors:  Reto Bale; Gerlig Widmann; Peter Schullian; Marion Haidu; Georg Pall; Alexander Klaus; Helmut Weiss; Matthias Biebl; Raimund Margreiter
Journal:  Eur Radiol       Date:  2011-11-10       Impact factor: 5.315

Review 2.  An Overview of the Current Management of Bilobar Colorectal Liver Metastases.

Authors:  Rebecca K L Griggs; Samir Pathak; Graeme Poston
Journal:  Indian J Surg Oncol       Date:  2017-08-09

3.  Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.

Authors:  Guoyi Wu; Bo Liu; Yingjun Zhang; Jing Li; Alla Arzumanyan; Marcia M Clayton; Raymond F Schinazi; Zhaohe Wang; Siegfried Goldmann; Qingyun Ren; Faxhou Zhang; Mark A Feitelson
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

Review 4.  Liver-directed therapies in metastatic colorectal cancer.

Authors:  Margaret E Clark; Richard R Smith
Journal:  J Gastrointest Oncol       Date:  2014-10

5.  Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases.

Authors:  Theodora Fifis; Caterina Malcontenti-Wilson; Jason Amijoyo; Beatrice Anggono; Vijayaragavan Muralidharan; Mehrdad Nikfarjam; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2011-03-02       Impact factor: 3.647

6.  Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent?

Authors:  Nathaniel P Reuter; Charles E Woodall; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  J Gastrointest Surg       Date:  2008-10-30       Impact factor: 3.452

7.  Intermittent Pringle maneuver may be beneficial for radiofrequency ablations in situations with tumor-vessel proximity.

Authors:  Franz G M Poch; Christina A Neizert; Ole Gemeinhardt; Beatrice Geyer; Katharina Eminger; Christian Rieder; Stefan M Niehues; Janis Vahldiek; Stefan F Thieme; Kai S Lehmann
Journal:  Innov Surg Sci       Date:  2018-05-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.